QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio Read More » September 11, 2025
Lupin Gets FDA Approval For Risperidone Long-Acting Injectable With CGT Exclusivity Read More » September 10, 2025
Immunic Secures U.S. Patent for Multiple Sclerosis Treatment Vidofludimus Calcium’s Dose Strengths Read More » September 9, 2025
Ascletis Reports ASC30 Half-Life of 36 Days, Enabling Once‑Monthly Dosing Read More » September 9, 2025
Glenmark Starts Phase 3 Trial of Envafolimab for Stage III Non-Small Cell Lung Cancer Read More » September 8, 2025
